Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reissue Patent
2007-04-24
2007-04-24
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S171000, C514S178000, C514S182000, C514S450000, C552S625000, C552S646000, C552S650000, C549S269000
Reissue Patent
active
11023337
ABSTRACT:
An extended release composition comprising a first composition comprising growth promoters and a second composition comprising growth promoters and a biodegradable polymer is described. A method of increasing weight gain in food animals utilizing the composition, a pharmaceutical dosage form containing the composition and a method of preparing the pharmaceutical dosage form are also described, as are pellets of the composition for implantation in food animals.
REFERENCES:
patent: 2232438 (1941-02-01), Butenandt
patent: 2236574 (1941-04-01), Koester et al.
patent: 2314185 (1943-03-01), Zondek et al.
patent: 2379832 (1945-07-01), Serini et al.
patent: 3239345 (1966-03-01), Hodge et al.
patent: 3248294 (1966-04-01), Nomine et al.
patent: 3773919 (1973-11-01), Boswell et al.
patent: 3939265 (1976-02-01), Grandadam
patent: 4166800 (1979-09-01), Fong
patent: 4192870 (1980-03-01), Grandadam et al.
patent: 4328204 (1982-05-01), Wasserman et al.
patent: 4331651 (1982-05-01), Reul et al.
patent: 4351337 (1982-09-01), Sidman
patent: 4389330 (1983-06-01), Tice et al.
patent: 4393041 (1983-07-01), Brown et al.
patent: 4450150 (1984-05-01), Sidman
patent: 4451253 (1984-05-01), Harman
patent: 4622244 (1986-11-01), Lapka et al.
patent: 4624665 (1986-11-01), Nuwayser
patent: 4687481 (1987-08-01), Nuwayser
patent: 4758435 (1988-07-01), Schaaf
patent: 4834978 (1989-05-01), Nuwayser
patent: 4874612 (1989-10-01), Deasy
patent: 4876093 (1989-10-01), Theeuwes et al.
patent: 4900735 (1990-02-01), Grandadam
patent: 4902515 (1990-02-01), Loomis et al.
patent: 4927687 (1990-05-01), Nuwayser
patent: 4940465 (1990-07-01), Theeuwes et al.
patent: 4981696 (1991-01-01), Loomis et al.
patent: 5000886 (1991-03-01), Lawter et al.
patent: 5035891 (1991-07-01), Runkel et al.
patent: 5143661 (1992-09-01), Lawter et al.
patent: 5147869 (1992-09-01), Grandadam
patent: 5183662 (1993-02-01), Morita et al.
patent: 5211952 (1993-05-01), Spicer et al.
patent: 5288496 (1994-02-01), Lewis
patent: 5340584 (1994-08-01), Spicer et al.
patent: 5340585 (1994-08-01), Pike et al.
patent: 5340586 (1994-08-01), Pike et al.
patent: 5366734 (1994-11-01), Hutchinson
patent: 5389379 (1995-02-01), Dirix
patent: 5401507 (1995-03-01), Lewis
patent: 5407609 (1995-04-01), Tice et al.
patent: 5419910 (1995-05-01), Lewis
patent: 5427796 (1995-06-01), Lewis
patent: 5434146 (1995-07-01), Labrie et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5534250 (1996-07-01), Klaveness et al.
patent: 5534263 (1996-07-01), Wong et al.
patent: 5541172 (1996-07-01), Labrie et al.
patent: 5620697 (1997-04-01), Tormala et al.
patent: 5629008 (1997-05-01), Lee
patent: 5629303 (1997-05-01), Labrie et al.
patent: 5633002 (1997-05-01), Stricker et al.
patent: 5643595 (1997-07-01), Lewis
patent: 5650173 (1997-07-01), Ramstack et al.
patent: 5654008 (1997-08-01), Herbert et al.
patent: 5667804 (1997-09-01), Wong et al.
patent: 5686092 (1997-11-01), Lewis
patent: 37 10 175 (1988-08-01), None
patent: 450 262 (1990-12-01), None
patent: 257 369 (1992-04-01), None
patent: 572 932 (1993-05-01), None
patent: 2 167 662 (1986-06-01), None
patent: 2 273 874 (1994-06-01), None
patent: WO 94/15636 (1994-07-01), None
patent: WO 96/12466 (1996-05-01), None
Deasy, P. et al., “Design and Evaluation of a Biodegradable Implant for Improved Delivery of Oestradiol-17β to Steers” (1993) International Journal of Pharmaceutics pp. 251-259.
Marcotte, N. et al.: “Delayed Release of Water-Soluble Macromolecules from Polylactide Pellets” (1989) Journal of Controlled Release, V9, pp. 75-85.
Foutz, C.P. et al. “Anabolic Implant Effects on Steer Performance, carcass Traits . . . ” J. Animal Science (1997) V75, pp. 1256-1265.
Henricks, D.M., et al “Serum Concentrations of Trenbolone-17β and Estradiol-17β and Performance of Heifers Treated . . . ” J. Animal Science (1997) V75 pp. 2627-2633.
Wuthrich, P. et al. “Pulsatile and delayed release of lysozyme from ointment-like polyl . . . ” J. Controlled Release (1992) V21, pp. 191-200.
Asano, M, et al. “In vivo controlled release of a luteinizing hormone-releasing hormone agonist . . . ” Intern. J. of Pharmaceutics (1997) V67, pp. 67-77, Netherlands.
Barnwell, S.G. et al. “Greatly enhanced oral bioavailability of propranolol using HALO liver by-pass drug deliver . . . ” Journal of Controlled Release (1994) V28, pp. 306-309.
Mehta, R.C. et al. “Biogradable microspheres as depot system for parenteral delivery of peptide drugs” J. of Controlled Release (1994) V29, pp. 375, U.S.A.
Ryden, L. et al. “Dextran microspheres as a nasal delivery system for insulin in rats” (1994) Journal of Controlled Release (1994) 29, pp. 394 U.S.A.
Jones, R. et al “In vitro and in vivo release of metroclopramide from a subdermal diffusion matrix . . . ” Journal of Controlled Release (1994) V30, pp. 35-44 U.S.A.
Macvinish, L.J., et al “The Effect of Implantation of Trenbolone Acetate and oestradiol17β in Wether Lambs . . . ” Animal Products (1988) V47, p. 75-85, GB.
Hanes, J. et al. “Degradation and Erosion of Tyrosene-Containing Polyahydrides . . . ” Proceedings of the Internat. Symp. on Controlled Release of Bioactive Materials (1994) 21,44.
Veronese et al. “Improved Enzyme Delivery By Surface Modification with Poly(vinylpyrrolidone) Oligomers” (1994) Proceedings of the Internat. Symp. on Controlled Release 21 298.
Gibson, J.W., et al. “Development of a Fibrous IUD Delivery System for Estradiol/Progesterone” Proceedings of an Internat. Workshop on Intrauterine Contraception . . . (1984) USA.
Ogawa, Y., et al. “In Vivo Release Profiles of Leuprolide Acetate from Microcapsules Prepared with Polylactic . . . ” Chemical and Pharmaceutical Bulletin (1988) 36, 2576, Japan.
Preston, R.L. “Comparative Effectiveness of Somatotropin and Anabolic Steriods in Feedlot Steers” J. of Animal Science (1995) V23, p. 1038-1047.
Sandow, J. et al. “Pharmacokinetics and Endocrine Effects of Slow Release Formulations of LHRH . . . ” J. of Steriod Biochemistry and Molecular Biology, V37, N36, p. 925-931, GB 1990.
Shah, N.H. et al “A biodegradable injectable implant for delivering micro and macromolecules . . . ” (1993) Netherlands.
Hwang, Ruey-ching et al. “Effect of Binder and Geometry of Tablet on Rate of Wear, Hardness and Tensile Strength” Drug Develop. and Industrial Pharmacy (1993) 19(5), 507-519.
Lewis, D. “Controlled Release Micrspheres Technology” (1995) Acad. of Veterinary Consultants, V23, p. 51.
Cady Susan Mancini
Gibson John W.
Macar Claude
Badio Barbara P.
Intervet Inc.
Kenyon & Kenyon
LandOfFree
Extended release growth promoting two component composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extended release growth promoting two component composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release growth promoting two component composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3781403